LABS:CC News and Press, Medipharm Labs Corp. From 11/08/23

MediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results Canada NewsWire TORONTO , Nov. 8, 2023 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company special...

MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to Cash Canada NewsWire TORONTO , Oct. 25, 2023 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a company ...

MediPharm Labs Settles an Outstanding Claim for $9M Canada NewsWire TORONTO , Oct. 2, 2023 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a company specialized in precision-based cannabinoids, i...

MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market Canada NewsWire The launch includes GMP strain-specific full spectrum cannabis oil and inhalation cartridge products to be distributed to patients under the MediPharm Labs Beacon Medical br...

MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement Canada NewsWire MediPharm Labs and Shelter Cannabis Brands have terminated their royalty agreement with a one-time cash payment. Agreement includes the elimina...

MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million PR Newswire MediPharm Labs sold vacant land in Napanee, Ontario last utilized in 2021 for outdoor cannabis growing activities. The land was acquired by MediPharm as part of the VIVO Cannabis acq...

MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia Patients PR Newswire MediPharm Labs wholly owned subsidiary Harvest Medicine has published a study in the peer-reviewed American Journal of Endocannabinoid ...

MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin Growth Canada NewsWire TORONTO , Aug. 14, 2023 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceu...

MediPharm Labs Sets Date to Report Second Quarter 2023 Financial Results Canada NewsWire TORONTO , Aug. 10, 2023 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company speci...

MediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner and Provides Update on US FDA Status Canada NewsWire MediPharm announces first delivery of pharmaceutical cannabis product for NIH funded clinical trial, following import permit from...